NASDAQ:COCP • US19188J4094
Past quarterly earnings results for COCRYSTAL PHARMA INC (COCP), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | -0.19 | -0.21 | 11.30% | 61.22% | - | - | ||
| Q2 2025 | -0.20 | -0.31 | 34.64% | 62.26% | - | - | ||
| Q1 2025 | -0.23 | -0.52 | 55.35% | 41.03% | - | - | ||
| Q4 2024 | -0.32 | -0.54 | 40.81% | 27.27% | - | - | ||
| Q3 2024 | -0.49 | -0.58 | 15.72% | -19.51% | - | - | ||
| Q2 2024 | -0.53 | -0.49 | -9.01% | -29.27% | - | - | ||
| Q1 2024 | -0.39 | -0.55 | 29.19% | 39.06% | - | - | ||
| Q4 2023 | -0.44 | -0.61 | 27.70% | 20.00% | - | - | ||
| Q3 2023 | -0.41 | -0.54 | 24.16% | 41.43% | - | - | ||
| Q2 2023 | -0.41 | -0.59 | 30.70% | 86.33% | 272.003K | -100.00% | - | |
| Q1 2023 | -0.64 | -0.69 | 7.04% | -33.33% | 255K | -100.00% | - | |
| Q4 2022 | -0.55 | -0.74 | 25.80% | -14.58% | - | - | ||
| Q3 2022 | -0.70 | -0.49 | -42.97% | -45.83% | 84.997K | -100.00% | - | |
| Q2 2022 | -3.00 | -0.53 | -465.65% | -525.00% | 84.997K | -100.00% | - | |
| Q1 2022 | -0.48 | -0.43 | -12.04% | - | 637.5K | -100.00% | - | |
| Q4 2021 | -0.48 | -0.49 | 1.96% | -100.00% | - | -100.00% | ||
| Q3 2021 | -0.48 | -0.49 | 1.96% | 20.00% | 280.5K | -100.00% | -100.00% | |
| Q2 2021 | -0.48 | -0.43 | -12.04% | 42.86% | 280.5K | -100.00% | -100.00% | |
| Q1 2021 | -0.48 | -0.55 | 12.85% | 20.00% | 561K | -100.00% | -100.00% | |
| Q4 2020 | -0.24 | -0.49 | 50.98% | - | 510K | 591.6K | -13.79% | - |
| Q3 2020 | -0.60 | -0.61 | 1.96% | - | 490K | 571.2K | -14.22% | - |
| Q2 2020 | -0.84 | -0.49 | -71.57% | - | 550K | 459K | 19.83% | - |
| Q1 2020 | -0.60 | -0.98 | 38.73% | - | 460K | - | - |
Notes
COCRYSTAL PHARMA INC (COCP) last reported earnings on 11/14/2025.
COCRYSTAL PHARMA INC (COCP) beat EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, COCRYSTAL PHARMA INC (COCP) has beaten EPS estimates in 4 out of 4 releases.